Drug Shortage Report for CALCIUM GLUCONATE INJECTION, USP 10%

Last updated on 2019-07-26 History
Report ID 88610
Drug Identification Number 02141019
Brand name CALCIUM GLUCONATE INJECTION, USP 10%
Common or Proper name Calcium Gluconate Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CALCIUM GLUCONATE
Strength(s) 94MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 100mL Vial
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-06-27
Estimated end date 2019-07-12
Actual end date 2019-07-24
Shortage status Resolved
Updated date 2019-07-26
Company comments Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be encountering a supply interruption with our Calcium Gluconate Injection, USP 10% 100 mg/mL Vial 100mL. Our Calcium Gluconate Injection, USP 10% 100 mg/mL Vial 50 mL will be available for substitution.
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-07-26 French Compare
v3 2019-07-26 English Compare
v2 2019-07-05 French Compare
v1 2019-07-05 English Compare